These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutation. Johnson WT, Patel P, Hernandez A, Grandinetti LM, Huen AC, Marks S, Ho J, Monaco SE, Jaffe R, Picarsic J. J Cutan Pathol; 2016 Mar 27; 43(3):270-5. PubMed ID: 26454140 [Abstract] [Full Text] [Related]
6. Hypoalphalipoproteinemia and BRAFV600E Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease. Cohen-Aubart F, Guerin M, Poupel L, Cluzel P, Saint-Charles F, Charlotte F, Arsafi Y, Emile JF, Frisdal E, Le Goff C, Donadieu J, Amoura Z, Lesnik P, Haroche J, Le Goff W. Arterioscler Thromb Vasc Biol; 2018 Aug 27; 38(8):1913-1925. PubMed ID: 29930009 [Abstract] [Full Text] [Related]
7. Abdominal involvement in Erdheim-Chester disease (ECD): MRI and CT imaging findings and their association with BRAFV600E mutation. Nikpanah M, Kim L, Mirmomen SM, Symons R, Papageorgiou I, Gahl WA, O'Brien K, Estrada-Veras JI, Malayeri AA. Eur Radiol; 2018 Sep 27; 28(9):3751-3759. PubMed ID: 29556768 [Abstract] [Full Text] [Related]
8. Thoracic involvement in Erdheim-Chester disease: computed tomography imaging findings and their association with the BRAFV600E mutation. Mirmomen SM, Sirajuddin A, Nikpanah M, Symons R, Paschall AK, Papageorgiou I, Gahl WA, O'Brien K, Estrada-Veras JI, Malayeri AA. Eur Radiol; 2018 Nov 27; 28(11):4635-4642. PubMed ID: 29736852 [Abstract] [Full Text] [Related]
9. BRAF V600E mutation in pediatric intracranial and cranial juvenile xanthogranuloma. Techavichit P, Sosothikul D, Chaichana T, Teerapakpinyo C, Thorner PS, Shuangshoti S. Hum Pathol; 2017 Nov 27; 69():118-122. PubMed ID: 28504206 [Abstract] [Full Text] [Related]
10. BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease. Cangi MG, Biavasco R, Cavalli G, Grassini G, Dal-Cin E, Campochiaro C, Guglielmi B, Berti A, Lampasona V, von Deimling A, Sabbadini MG, Ferrarini M, Doglioni C, Dagna L. Ann Rheum Dis; 2015 Aug 27; 74(8):1596-602. PubMed ID: 24671772 [Abstract] [Full Text] [Related]
11. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation. Hervier B, Haroche J, Arnaud L, Charlotte F, Donadieu J, Néel A, Lifermann F, Villabona C, Graffin B, Hermine O, Rigolet A, Roubille C, Hachulla E, Carmoi T, Bézier M, Meignin V, Conrad M, Marie L, Kostrzewa E, Michot JM, Barete S, Taly V, Cury K, Emile JF, Amoura Z, French Histiocytoses Study Group. Blood; 2014 Aug 14; 124(7):1119-26. PubMed ID: 24894769 [Abstract] [Full Text] [Related]
12. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders. Papo M, Cohen-Aubart F, Trefond L, Bauvois A, Amoura Z, Emile JF, Haroche J. Curr Oncol Rep; 2019 May 21; 21(7):62. PubMed ID: 31115724 [Abstract] [Full Text] [Related]
13. BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease. Janku F, Vibat CR, Kosco K, Holley VR, Cabrilo G, Meric-Bernstam F, Stepanek VM, Lin PP, Leppin L, Hassaine L, Poole JC, Kurzrock R, Erlander MG. Oncotarget; 2014 Jun 15; 5(11):3607-10. PubMed ID: 25003820 [Abstract] [Full Text] [Related]
14. The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease. Dai JW, Lin H, Chang L, Li J, Zhou DB, Cao XX. Ann Hematol; 2023 Dec 15; 102(12):3335-3343. PubMed ID: 37922006 [Abstract] [Full Text] [Related]
17. Does the BRAF(V600E) mutation herald a new treatment era for Erdheim-Chester disease? A case-based review of a rare and difficult to diagnose disorder. Bosco J, Allende A, Varikatt W, Lee R, Stewart GJ. Intern Med J; 2015 Mar 15; 45(3):348-51. PubMed ID: 25735579 [Abstract] [Full Text] [Related]
18. Dramatic efficacy of dabrafenib in Erdheim-Chester disease (ECD): a pediatric patient with multiple large intracranial ECD lesions hidden by refractory Langerhans cell histiocytosis. Hao X, Feng R, Bi Y, Liu Y, Li C, Lu T, Tian Y. J Neurosurg Pediatr; 2019 Jan 01; 23(1):48-53. PubMed ID: 30265230 [Abstract] [Full Text] [Related]
19. Erdheim-Chester disease with bilateral Achilles tendon involvement. Nadjiri J, Woertler K, Specht K, Harrasser N, Toepfer A. Skeletal Radiol; 2016 Oct 01; 45(10):1437-42. PubMed ID: 27506209 [Abstract] [Full Text] [Related]
20. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults. Milne P, Bigley V, Bacon CM, Néel A, McGovern N, Bomken S, Haniffa M, Diamond EL, Durham BH, Visser J, Hunt D, Gunawardena H, Macheta M, McClain KL, Allen C, Abdel-Wahab O, Collin M. Blood; 2017 Jul 13; 130(2):167-175. PubMed ID: 28512190 [Abstract] [Full Text] [Related] Page: [Next] [New Search]